Atenolol treatment for infantile haemangioma

Br J Dermatol. 2017 May;176(5):1400-1402. doi: 10.1111/bjd.15317. Epub 2017 Mar 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adrenergic beta-1 Receptor Antagonists / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Atenolol / administration & dosage*
  • Female
  • Hemangioma / drug therapy*
  • Humans
  • Infant
  • Male
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Antineoplastic Agents
  • Atenolol